结构:[Na+]
HCID923

Sodium ion

sodium(1+)

Na+22.9898 g/molCAS 17341-25-2

IDENTITY

结构与身份

标准 SMILES
[Na+]
InChIKey
FKNQFGJONOIPTF-UHFFFAOYSA-N
分子式
Na+
平均分子量
22.9898 g/mol
单同位素质量
22.98976928

COMPUTED

结构计算性质

已同步
极性表面积
0 Ų
氢键供体
0
氢键受体
0
可旋转键
0
重原子
1
形式电荷
1
复杂度
0

PROPERTIES

实验与物化性质

来源:PubChem
Melting Point

97.82 °C

Physical Description

Solid

PHARMACOLOGY

药理信息

来源:PubChem
FDA Pharmacological Classification

LYR4M0NH37

SODIUM CATION

Established Pharmacologic Class [EPC] - Osmotic Laxative

Physiologic Effects [PE] - Increased Large Intestinal Motility

Physiologic Effects [PE] - Inhibition Large Intestine Fluid/Electrolyte Absorption

Mechanisms of Action [MoA] - Osmotic Activity

Tissue Locations

Kidney

Cellular Locations

Extracellular;Golgi apparatus;Peroxisome

Metabolite Pathways

3-Methylthiofentanyl Action Pathway;Acebutolol Action Pathway;Alfentanil Action Pathway;Alprenolol Action Pathway;Alvimopan Action Pathway;Amiloride Action Pathway;Amiodarone Action Pathway;Amlodipine Action Pathway;Anileridine Action Pathway;Arbutamine Action Pathway;Total 139 pathways, visit the HMDB page for details

ALIASES

名称与别名

37
sodium ionSodium(1+)sodium cation17341-25-2Sodium, ion (Na1+)Sodium (ion)Sodium ion(1+)LYR4M0NH37124224-04-0Na+4-Aza-5-thiatricyclo[5.2.1.0(3,7)]decane-5,5-dioxide, (7S)-10,10-dimet hyl-Sodium(1+)ionsUNII-LYR4M0NH37sodium(I)Sodium ion(+)Sodium cation(1+)Sodium (Na1+)Sodium ion (Na1+)Sodium (1+)SODIUM ION CHROMATOGRAPHY STANDARD

REACTIONS

参与反应

102,045
HRID85811

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85811 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85813

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85813 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85827

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85827 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85833

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85833 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85836

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85836 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85842

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85842 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85846

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85846 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID85849

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 85849 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物